At IDS2024 today, Samia Hamdan presented how DiaUnion now uses ADAP (Antibody Detection by Agglutination-PCR) multiplex assays as the first line of screening.
This means that screening for all three diseases in DiaUnion 2.0, type 1 diabetes, celiac disease and autoimmune thyroiditis, is performed in a single laboratory process, saving time, cost and human resources.
By combining multiplex assays with laboratory automation, such as a pipette robot, in DiaUnion 2.0, analyzes that previously took a week to complete can now be performed in one day.